Article
Evaluation of the Blood and Serum Biomarkers for the Prognosis and Progression of the ALS Disease by Eliminating the Effects of Aging
2022-03-14
Abstract excerpt
Amyotrophic Lateral Sclerosis (ALS) is the most common motor neuron disease. There are no pathognomonic tests for ALS prognosis; clinical diagnosis of the disease takes time and is usually difficult. Prognostic biomarkers are urgently needed for rapid and effective ALS prognosis. Male albino rats were divided into ten groups based on age as 0 (40–45 days old), A (70–75 days old), B (90–95 days old), C (110–115 day...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5b2d8132-42f5-5c67-bb39-d9673a620481
- DOI
- 10.21203/rs.3.rs-1427688/v1
